PDB Short entry for 3ZSH HEADER TRANSFERASE 28-JUN-11 3ZSH TITLE X-RAY STRUCTURE OF P38ALPHA BOUND TO SCIO-469 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE 14, MAPK 14, CYTOKINE SUPPRESSIVE ANTI- COMPND 5 INFLAMMATORY DRUG-BINDING PROTEIN, CSAID-BINDING PROTEIN, CSBP, MAP COMPND 6 KINASE MXI2, MAX-INTERACTING PROTEIN 2, MITOGEN-ACTIVATED PROTEIN COMPND 7 KINASE P38 ALPHA, MAP KINASE P38 ALPHA, SAPK2A, P38A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMAL-C2X LIKE KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.AZEVEDO,M.VAN ZEELAND,H.RAAIJMAKERS,B.KAZEMIER,A.OUBRIE REVDAT 5 29-JUL-20 3ZSH 1 COMPND REMARK HETNAM SITE REVDAT 4 07-FEB-18 3ZSH 1 JRNL REVDAT 3 15-AUG-12 3ZSH 1 JRNL REVDAT 2 25-JUL-12 3ZSH 1 JRNL REVDAT 1 13-JUN-12 3ZSH 0 JRNL AUTH R.AZEVEDO,M.VAN ZEELAND,H.RAAIJMAKERS,B.KAZEMIER,J.DE VLIEG, JRNL AUTH 2 A.OUBRIE JRNL TITL X-RAY STRUCTURE OF P38 ALPHA BOUND TO TAK-715: COMPARISON JRNL TITL 2 WITH THREE CLASSIC INHIBITORS. JRNL REF ACTA CRYSTALLOGR. D BIOL. V. 68 1041 2012 JRNL REF 2 CRYSTALLOGR. JRNL REFN ESSN 1399-0047 JRNL PMID 22868770 JRNL DOI 10.1107/S090744491201997X REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.15 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 21887 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1189 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.10 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1553 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.38 REMARK 3 BIN R VALUE (WORKING SET) : 0.2230 REMARK 3 BIN FREE R VALUE SET COUNT : 90 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2674 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 205 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.16000 REMARK 3 B22 (A**2) : -0.14000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.234 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.196 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.150 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.024 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2837 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1930 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3862 ; 1.309 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4714 ; 0.849 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 340 ; 6.204 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 132 ;33.373 ;23.939 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 491 ;15.409 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;13.403 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 434 ; 0.076 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3090 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 564 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1677 ; 0.749 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 664 ; 0.156 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2728 ; 1.347 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1160 ; 1.711 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1129 ; 2.734 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 5 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 4 A 28 REMARK 3 RESIDUE RANGE : A 40 A 166 REMARK 3 RESIDUE RANGE : A 185 A 240 REMARK 3 RESIDUE RANGE : A 266 A 321 REMARK 3 RESIDUE RANGE : A 1353 A 1353 REMARK 3 ORIGIN FOR THE GROUP (A): 11.8860 31.5120 16.7020 REMARK 3 T TENSOR REMARK 3 T11: 0.0852 T22: 0.0186 REMARK 3 T33: 0.0612 T12: -0.0273 REMARK 3 T13: 0.0093 T23: 0.0124 REMARK 3 L TENSOR REMARK 3 L11: 2.1112 L22: 0.7362 REMARK 3 L33: 0.9957 L12: -0.5141 REMARK 3 L13: 0.2834 L23: -0.0370 REMARK 3 S TENSOR REMARK 3 S11: 0.0391 S12: 0.0545 S13: 0.1737 REMARK 3 S21: 0.0068 S22: -0.0370 S23: -0.0633 REMARK 3 S31: -0.1768 S32: 0.1182 S33: -0.0021 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 241 A 265 REMARK 3 ORIGIN FOR THE GROUP (A): -13.1110 30.1160 36.6310 REMARK 3 T TENSOR REMARK 3 T11: 0.1817 T22: 0.2325 REMARK 3 T33: 0.1897 T12: -0.0520 REMARK 3 T13: 0.1235 T23: -0.0130 REMARK 3 L TENSOR REMARK 3 L11: 5.4369 L22: 11.1791 REMARK 3 L33: 9.6977 L12: -4.5602 REMARK 3 L13: 4.6446 L23: -0.2130 REMARK 3 S TENSOR REMARK 3 S11: -0.0425 S12: -0.4413 S13: 0.4192 REMARK 3 S21: 0.7938 S22: -0.1658 S23: 0.2752 REMARK 3 S31: -0.1897 S32: -1.0616 S33: 0.2084 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 322 A 347 REMARK 3 ORIGIN FOR THE GROUP (A): 25.8200 17.1210 28.4310 REMARK 3 T TENSOR REMARK 3 T11: 0.0363 T22: 0.0771 REMARK 3 T33: 0.1037 T12: -0.0252 REMARK 3 T13: -0.0328 T23: 0.0198 REMARK 3 L TENSOR REMARK 3 L11: 4.3213 L22: 1.3713 REMARK 3 L33: 14.0314 L12: -0.9985 REMARK 3 L13: 2.5192 L23: -3.2843 REMARK 3 S TENSOR REMARK 3 S11: 0.1590 S12: -0.4126 S13: -0.0780 REMARK 3 S21: -0.1752 S22: 0.2335 S23: 0.0221 REMARK 3 S31: 0.6789 S32: -0.2909 S33: -0.3924 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 3ZSH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1290048842. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU-MSC R-AXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27241 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 40.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.93 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.94000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.36000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.14500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.04000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.14500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.36000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.04000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 HIS A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 ASN A 14 REMARK 465 LYS A 15 REMARK 465 THR A 16 REMARK 465 PHE A 169 REMARK 465 GLY A 170 REMARK 465 LEU A 171 REMARK 465 ALA A 172 REMARK 465 ARG A 173 REMARK 465 HIS A 174 REMARK 465 THR A 175 REMARK 465 ASP A 176 REMARK 465 ASP A 177 REMARK 465 GLU A 178 REMARK 465 MET A 179 REMARK 465 THR A 180 REMARK 465 GLY A 181 REMARK 465 TYR A 182 REMARK 465 VAL A 183 REMARK 465 LEU A 353 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O THR A 185 O HOH A 2113 1.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 32 85.90 15.60 REMARK 500 ARG A 149 -16.33 85.19 REMARK 500 ASP A 150 51.32 -144.42 REMARK 500 CYS A 162 35.26 39.43 REMARK 500 MET A 198 -160.14 62.95 REMARK 500 PHE A 274 50.83 -103.27 REMARK 500 LEU A 289 51.65 -97.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU A 167 ASP A 168 147.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BAJ RELATED DB: PDB REMARK 900 P38ALPHA BOUND TO PYRAZOLOUREA REMARK 900 RELATED ID: 1WFC RELATED DB: PDB REMARK 900 STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATEDPROTEIN REMARK 900 KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUEOF THE YEAST REMARK 900 HOG1 PROTEIN REMARK 900 RELATED ID: 1W7H RELATED DB: PDB REMARK 900 P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1WBO RELATED DB: PDB REMARK 900 FRAGMENT BASED P38 INHIBITORS REMARK 900 RELATED ID: 1KV2 RELATED DB: PDB REMARK 900 HUMAN P38 MAP KINASE IN COMPLEX WITH BIRB 796 REMARK 900 RELATED ID: 1YQJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH A REMARK 900 SELECTIVEPYRIDAZINE INHIBITOR REMARK 900 RELATED ID: 1BMK RELATED DB: PDB REMARK 900 THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655 REMARK 900 RELATED ID: 1BL7 RELATED DB: PDB REMARK 900 THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025 REMARK 900 RELATED ID: 1ZYJ RELATED DB: PDB REMARK 900 HUMAN P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1A REMARK 900 RELATED ID: 1A9U RELATED DB: PDB REMARK 900 THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580 REMARK 900 RELATED ID: 1WBT RELATED DB: PDB REMARK 900 IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING REMARK 900 FRAGMENT-BASED LEAD GENERATION. REMARK 900 RELATED ID: 2I0H RELATED DB: PDB REMARK 900 THE STRUCTURE OF P38ALPHA IN COMPLEX WITH ANARYLPYRIDAZINONE REMARK 900 RELATED ID: 3ZS5 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR KINASE SELECTIVITY OF THREE CLINICAL P38ALPHA REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2YIW RELATED DB: PDB REMARK 900 TRIAZOLOPYRIDINE INHIBITORS OF P38 KINASE REMARK 900 RELATED ID: 2BAQ RELATED DB: PDB REMARK 900 P38ALPHA BOUND TO RO3201195 REMARK 900 RELATED ID: 1ZZ2 RELATED DB: PDB REMARK 900 TWO CLASSES OF P38ALPHA MAP KINASE INHIBITORS HAVING ACOMMON REMARK 900 DIPHENYLETHER CORE BUT EXHIBITING DIVERGENT BINDINGMODES REMARK 900 RELATED ID: 1WBV RELATED DB: PDB REMARK 900 IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING REMARK 900 FRAGMENT-BASED LEAD GENERATION. REMARK 900 RELATED ID: 1DI9 RELATED DB: PDB REMARK 900 THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE INCOMPLEX REMARK 900 WITH 4-[3-METHYLSULFANYLANILINO]-6,7- DIMETHOXYQUINAZOLINE REMARK 900 RELATED ID: 1W83 RELATED DB: PDB REMARK 900 P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1BL6 RELATED DB: PDB REMARK 900 THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995 REMARK 900 RELATED ID: 1M7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF P38 MAP KINASE IN COMPLEX WITH REMARK 900 ADIHYDROQUINAZOLINONE INHIBITOR REMARK 900 RELATED ID: 1IAN RELATED DB: PDB REMARK 900 HUMAN P38 MAP KINASE INHIBITOR COMPLEX REMARK 900 RELATED ID: 1OZ1 RELATED DB: PDB REMARK 900 P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4- AZAINDOLEINHIBITOR REMARK 900 RELATED ID: 1WBN RELATED DB: PDB REMARK 900 FRAGMENT BASED P38 INHIBITORS REMARK 900 RELATED ID: 2BAK RELATED DB: PDB REMARK 900 P38ALPHA MAP KINASE BOUND TO MPAQ REMARK 900 RELATED ID: 1WBS RELATED DB: PDB REMARK 900 IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING REMARK 900 FRAGMENT-BASED LEAD GENERATION. REMARK 900 RELATED ID: 2BAL RELATED DB: PDB REMARK 900 P38ALPHA MAP KINASE BOUND TO PYRAZOLOAMINE REMARK 900 RELATED ID: 1OUY RELATED DB: PDB REMARK 900 THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROPYRIDO- REMARK 900 PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1OUK RELATED DB: PDB REMARK 900 THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH APYRIDINYLIMIDAZOLE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2Y8O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A MAPK DOCKING REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1R39 RELATED DB: PDB REMARK 900 THE STRUCTURE OF P38ALPHA REMARK 900 RELATED ID: 2YIS RELATED DB: PDB REMARK 900 TRIAZOLOPYRIDINE INHIBITORS OF P38 KINASE. REMARK 900 RELATED ID: 1KV1 RELATED DB: PDB REMARK 900 P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1 REMARK 900 RELATED ID: 1WBW RELATED DB: PDB REMARK 900 IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING REMARK 900 FRAGMENT-BASED LEAD GENERATION. REMARK 900 RELATED ID: 1W82 RELATED DB: PDB REMARK 900 P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2YIX RELATED DB: PDB REMARK 900 TRIAZOLOPYRIDINE INHIBITORS OF P38 REMARK 900 RELATED ID: 1OVE RELATED DB: PDB REMARK 900 THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH ADIHYDROQUINOLINONE REMARK 900 RELATED ID: 1R3C RELATED DB: PDB REMARK 900 THE STRUCTURE OF P38ALPHA C162S MUTANT REMARK 900 RELATED ID: 1W84 RELATED DB: PDB REMARK 900 P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1ZZL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF P38 WITH TRIAZOLOPYRIDINE REMARK 900 RELATED ID: 3ZSI RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF P38ALPHA BOUND TO VX-745 REMARK 900 RELATED ID: 3ZSG RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF P38ALPHA BOUND TO TAK-715 DBREF 3ZSH A 2 360 UNP Q16539 MK14_HUMAN 2 360 SEQADV 3ZSH GLY A -1 UNP Q16539 EXPRESSION TAG SEQADV 3ZSH SER A 0 UNP Q16539 EXPRESSION TAG SEQADV 3ZSH HIS A 1 UNP Q16539 EXPRESSION TAG SEQRES 1 A 362 GLY SER HIS SER GLN GLU ARG PRO THR PHE TYR ARG GLN SEQRES 2 A 362 GLU LEU ASN LYS THR ILE TRP GLU VAL PRO GLU ARG TYR SEQRES 3 A 362 GLN ASN LEU SER PRO VAL GLY SER GLY ALA TYR GLY SER SEQRES 4 A 362 VAL CYS ALA ALA PHE ASP THR LYS THR GLY LEU ARG VAL SEQRES 5 A 362 ALA VAL LYS LYS LEU SER ARG PRO PHE GLN SER ILE ILE SEQRES 6 A 362 HIS ALA LYS ARG THR TYR ARG GLU LEU ARG LEU LEU LYS SEQRES 7 A 362 HIS MET LYS HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL SEQRES 8 A 362 PHE THR PRO ALA ARG SER LEU GLU GLU PHE ASN ASP VAL SEQRES 9 A 362 TYR LEU VAL THR HIS LEU MET GLY ALA ASP LEU ASN ASN SEQRES 10 A 362 ILE VAL LYS CYS GLN LYS LEU THR ASP ASP HIS VAL GLN SEQRES 11 A 362 PHE LEU ILE TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE SEQRES 12 A 362 HIS SER ALA ASP ILE ILE HIS ARG ASP LEU LYS PRO SER SEQRES 13 A 362 ASN LEU ALA VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU SEQRES 14 A 362 ASP PHE GLY LEU ALA ARG HIS THR ASP ASP GLU MET THR SEQRES 15 A 362 GLY TYR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE SEQRES 16 A 362 MET LEU ASN TRP MET HIS TYR ASN GLN THR VAL ASP ILE SEQRES 17 A 362 TRP SER VAL GLY CYS ILE MET ALA GLU LEU LEU THR GLY SEQRES 18 A 362 ARG THR LEU PHE PRO GLY THR ASP HIS ILE ASP GLN LEU SEQRES 19 A 362 LYS LEU ILE LEU ARG LEU VAL GLY THR PRO GLY ALA GLU SEQRES 20 A 362 LEU LEU LYS LYS ILE SER SER GLU SER ALA ARG ASN TYR SEQRES 21 A 362 ILE GLN SER LEU THR GLN MET PRO LYS MET ASN PHE ALA SEQRES 22 A 362 ASN VAL PHE ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU SEQRES 23 A 362 LEU GLU LYS MET LEU VAL LEU ASP SER ASP LYS ARG ILE SEQRES 24 A 362 THR ALA ALA GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN SEQRES 25 A 362 TYR HIS ASP PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR SEQRES 26 A 362 ASP GLN SER PHE GLU SER ARG ASP LEU LEU ILE ASP GLU SEQRES 27 A 362 TRP LYS SER LEU THR TYR ASP GLU VAL ILE SER PHE VAL SEQRES 28 A 362 PRO PRO PRO LEU ASP GLN GLU GLU MET GLU SER HET 469 A 400 36 HET BOG A1353 20 HETNAM 469 2-(6-CHLORO-5-{[(2R,5S)-4-(4-FLUOROBENZYL)-2,5- HETNAM 2 469 DIMETHYLPIPERAZIN-1-YL]CARBONYL}-1-METHYL-1H-INDOL-3- HETNAM 3 469 YL)-N,N-DIMETHYL-2-OXOACETAMIDE HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE FORMUL 2 469 C27 H30 CL F N4 O3 FORMUL 3 BOG C14 H28 O6 FORMUL 4 HOH *205(H2 O) HELIX 1 1 SER A 61 MET A 78 1 18 HELIX 2 2 LEU A 113 LYS A 118 1 6 HELIX 3 3 THR A 123 ALA A 144 1 22 HELIX 4 4 LYS A 152 SER A 154 5 3 HELIX 5 5 ALA A 184 ARG A 189 5 6 HELIX 6 6 ALA A 190 LEU A 195 1 6 HELIX 7 7 THR A 203 GLY A 219 1 17 HELIX 8 8 ASP A 227 GLY A 240 1 14 HELIX 9 9 GLY A 243 LYS A 248 1 6 HELIX 10 10 SER A 252 SER A 261 1 10 HELIX 11 11 ASN A 269 PHE A 274 1 6 HELIX 12 12 ASN A 278 LEU A 289 1 12 HELIX 13 13 ASP A 292 ARG A 296 5 5 HELIX 14 14 THR A 298 ALA A 304 1 7 HELIX 15 15 HIS A 305 ALA A 309 5 5 HELIX 16 16 GLN A 325 ARG A 330 5 6 HELIX 17 17 LEU A 333 PHE A 348 1 16 SHEET 1 AA 2 PHE A 8 GLN A 11 0 SHEET 2 AA 2 TRP A 18 PRO A 21 -1 O TRP A 18 N GLN A 11 SHEET 1 AB 5 TYR A 24 GLY A 33 0 SHEET 2 AB 5 GLY A 36 ASP A 43 -1 N GLY A 36 O GLY A 33 SHEET 3 AB 5 LEU A 48 LYS A 54 -1 O LEU A 48 N ASP A 43 SHEET 4 AB 5 TYR A 103 HIS A 107 -1 O LEU A 104 N LYS A 53 SHEET 5 AB 5 ASP A 88 PHE A 90 -1 O ASP A 88 N VAL A 105 SHEET 1 AC 3 ALA A 111 ASP A 112 0 SHEET 2 AC 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 AC 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 CRYST1 68.720 70.080 74.290 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014552 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014269 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013461 0.00000